Overview

The Effect of High Dose Simvastatine on Multiple Myeloma

Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the effect of high doses of Simvastatine on bone metabolisme and biochemical markers of disease in Multiple Myeloma
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Vejle Hospital
Treatments:
Simvastatin